Erik H.F. Wong - Concepedia

Author

Erik H.F. Wong

Pfizer (United States)

Also Known As

E H F Wong, E H Wong, E Wong, E. H. F. WONG, E. H. F. Wong, E. H.F. Wong, E. WONG, E. Wong, E.H.F WONG, E.H.F. Wong

107

Publications

9.1K

Citations

H-Index

114

Concepts

All Affiliations

Pfizer (United States)Merck & Co., Inc., Rahway, NJ, USA (United States)Institute of Organic Chemistry AstraZeneca (United States)NHS Lanarkshire

About

Erik H.F. Wong is an author at Pfizer (United States) specializing in medicine, neuropharmacology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	51	5.2K
2	Health Sciences	4	4	191
3	Business	1	1	11
4	Engineering	1	1	40
5	Management	1	1	11

Erik H.F. Wong

Publications

8.2K

Citations

H-Index

Page 1

	Year	Citations
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Erik H.F. Wong, J A Kemp, Tony Priestley, Proceedings of the National Academy of Sciences Mk-801 Binding SitesNeurotransmitterPsychopharmacologyPharmacotherapySocial Sciences	1986	1.8K
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress Georgia E. Hodes, Madeline L. Pfau, Marylène Leboeuf, Proceedings of the National Academy of Sciences	2014	684
Non-competitive antagonists of excitatory amino acid receptors John A. Kemp, Alan C. Foster, Erik H.F. Wong Trends in Neurosciences Functional SelectivityMedicinePhysiologyNeuropharmacologyNon-peptide Ligand	1987	499
[<sup>3</sup>H]MK‐801 Labels a Site on the <i>N</i>‐Methyl‐D‐Aspartate Receptor Channel Complex in Rat Brain Membranes Erik H.F. Wong, Antony R. Knight, Geoffrey N. Woodruff Journal of Neurochemistry	1988	456
The novel anticonvulsant MK‐801 binds to the activated state of the N‐methyl‐<scp>d</scp>‐aspartate receptor in rat brain Alan C. Foster, Erik H.F. Wong British Journal of Pharmacology	1987	450
Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor Erik H.F. Wong, Mark S. Sonders, Susan Amara, Biological Psychiatry Molecular PharmacologyPharmacological StudyPsychotropic MedicationPharmacologyNeuropharmacology	2000	336
Discovery and Structure−Activity Relationship of Quinuclidine Benzamides as Agonists of α7 Nicotinic Acetylcholine Receptors Alice L. Bodnar, Luz Cortes-Burgos, Karen K. Cook, Journal of Medicinal Chemistry PharmacotherapyChemical BiologyMolecular PharmacologyMedicinal ChemistryQuinuclidine Benzamides	2005	214
5‐Hydroxytryptamine (5‐HT)<sub>4</sub> receptors in <i>post mortem</i> human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases Gavin P. Reynolds, Sarah Mason, A. Meldrum, British Journal of Pharmacology NeurotransmitterHill CoefficientsSocial SciencesMolecular PharmacologyHuman Putamen	1995	198
Discovery of<i>N</i>-[(3<i>R</i>)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-<i>c</i>]pyridine-5-carboxamide, an Agonist of the α7 Nicotinic Acetylcholine Receptor, for the Potential Treatment of Cognitive Deficits in Schizophrenia: Synthesis and Structure−Activity Relationship Donn G. Wishka, Daniel P. Walker, Karen M. Yates, Journal of Medicinal Chemistry NeuropsychologyCompound 14PsychopharmacologyPharmacotherapySocial Sciences	2006	188
Quantitative autoradiography of [<sup>3</sup>H]‐MK‐801 binding sites in mammalian brain Norman G. Bowery, Erik H.F. Wong, Alan L. Hudson British Journal of Pharmacology	1988	175

Page 1